New painkiller candidate MT-8554 tested in healthy men
NCT ID NCT02536209
First seen Jan 08, 2026 · Last updated Jun 22, 2026 · Updated 25 times
Summary
This early-stage study tested a single dose of MT-8554, a new drug being developed for pain, in 20 healthy men. Researchers measured how the drug affects the body's response to a cold-induced pain test and checked for safety. The goal was to gather initial data, not to treat any condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Investigational center
City Name, United Kingdom
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
MT-8554
What this could lead to
If successful, this could point toward a new painkiller that works differently from existing options.
What could go wrong
This is a very early Phase 1 trial in just 20 healthy people, so it cannot predict real-world pain relief or safety in patients. The drug may not work or could have side effects.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.